Tuesday, 18 June 2019
The Medicines Control Authority of Zimbabwe (MCAZ) Regional Centre of Regulatory Excellence
(ReCORE) in partnership with the European and Developing Countries Clinical Trials Partnership
(EDCTP) is offering a 2-year fellowship in regulatory science to 8 – 10 assessors working in African medicines regulatory authorities (MRA). Fellows will be admitted in two groups, the first in 2019 and the second group in 2020. The MCAZ is a leading regulator on the African continent and has trained regulators from all over the continent for many years.
The fellowship will involve completion of short courses through block release training at the MCAZ / University of Zimbabwe (UZ), completion of the summer course and winter mini-conference at the Utrecht-WHO Collaborating Centre for Pharmaceutical Policy and Regulation in the Netherlands, practical work assignments, case studies, specific hours of practice (dossier assessments) over the fellowship period and a capstone project. The capstone project should be in the area of specialisation selected by the fellow and address a specific problem, issue or research question in regulatory science. Funding will be provided for 8 fellows and 2 additional fellows will be accepted provided they can fund themselves. The approximate cost of the fellowship is US$28 950 for the entire fellowship period.
In line with the WHO guidelines on variations and other SRA guidelines, the EVR Division is updating the MCAZ Guidelines for submitting applications for Variations to Registered Medicines. The update...
SCHOLARSHIP OPPORTUNITIES The Medicines Control Authority of Zimbabwe (MCAZ) is inviting applications from hard-working, well-disciplined, honest and self-motivated students for a scholarship opportunity. Eligibility Part III or Part IV University...
Background The Medicines Control Authority of Zimbabwe (MCAZ) Regional Centre of Regulatory Excellence (ReCORE) in partnership with the European and Developing Countries Clinical Trials Partnership (EDCTP) is offering...
The Quality Policy of the Medicines Control Authority of Zimbabwe (MCAZ) is to ensure the provision of accurate and timeous services, continuously meet requirements of our customers and guarantee patient...
In this issue: MCAZ turns 20 years Basics of reporting Side Effects of medicines Electronic Adverse Drug Reaction Reporting For more information Please click here to download the Newsletter...
Increased Reporting from the Targeted Spontaneous Reporting (TSR) Programme Click here to download Drug Information Bulletin
Download Complementary medicines applications extension - press statement
The aims of the PV policy handbook are to firstly provide a framework for a national pharmacovigilance system in Zimbabwe. Secondly, to define the pharmacovigilance activities undertaken by the Pharmacovigilance...
The Medicines Control Authority of Zimbabwe (MCAZ) as a responsible corporate citizen runs a Scholarship Fund as part of its corporate social responsibility programmes. Click here to download the...
The approved Guidelines for Advertising and Promotion of Medicines are now available. Download the Guidelines for Advertising and Promotion of Medicines
The Medicines Control Authority of Zimbabwe is responsible for the evaluation of safety, efficacy and quality and registration of complementary medicines destined for use in Zimbabwe. Please see the documents...
The MCAZ Chemistry and Medical Devices laboratories are now accredited to the ISO/IEC 17025 standard through the Southern African Development Community Accreditation Service (SADCAS). The Chemistry laboratory is accredited for...
The ZAZIBONA process is a collaboration between national medicines regulatory authorities (NMRAs) in Botswana, Namibia, Zambia, and Zimbabwe. These are four neighbouring countries in Southern Africa which have a...